Board of Directors authorized a program to repurchase up to $400 million of Lantheus (LNTH) common stock, replacing the 12-month program announced in November 2024
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LNTH:
- Lantheus: Strong Market Position and Growth Potential Justify Buy Rating
- Analysts Spot 3 Strong Buy Russell 2000 Stocks with 100% Upside
- Positive Outlook for Lantheus: Strategic Adjustments and Steady Price Target Support Buy Rating
- Lantheus Completes Acquisition of Life Molecular Imaging
- Lantheus completes acquisition of Life Molecular Imaging